Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1988 Nov;26(5):503–508. doi: 10.1111/j.1365-2125.1988.tb05289.x

Ebastine: the effect of a new antihistamine on psychomotor performance and autonomic responses in healthy subjects.

J Vincent 1, D J Sumner 1, J L Reid 1
PMCID: PMC1386626  PMID: 2905151

Abstract

1. Ebastine, through its carboxylic acid metabolite has antihistamine (H1-receptor) activity in man. 2. We have examined in a single blind placebo controlled study the effects of 10 mg and 50 mg of ebastine on cardiovascular, autonomic and psychomotor function in healthy subjects. 3. Ebastine had no effect on blood pressure or heart rate and there was no evidence of any anticholinergic activity on circulatory reflexes or salivation. 4. Ebastine did not impair psychomotor performance as assessed by critical flicker fusion at either dose. 5. Ebastine 10 mg had no effect on sedation measured by visual analogue scale or direct questioning, however ebastine 50 mg did cause a modest increase in indices of sedation. 6. Ebastine did not have detectable sedative properties at the 10 mg dose where long-lasting antihistamine effects can be demonstrated.

Full text

PDF
503

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bellavere F., Ewing D. J. Autonomic control of the immediate heart rate response to lying down. Clin Sci (Lond) 1982 Jan;62(1):57–64. doi: 10.1042/cs0620057. [DOI] [PubMed] [Google Scholar]
  2. Carruthers S. G., Shoeman D. W., Hignite C. E., Azarnoff D. L. Correlation between plasma diphenhydramine level and sedative and antihistamine effects. Clin Pharmacol Ther. 1978 Apr;23(4):375–382. doi: 10.1002/cpt1978234375. [DOI] [PubMed] [Google Scholar]
  3. Clarke C. H., Nicholson A. N. Performance studies with antihistamines. Br J Clin Pharmacol. 1978 Jul;6(1):31–35. doi: 10.1111/j.1365-2125.1978.tb01678.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cohen A. F., Hamilton M., Philipson R., Peck A. W. The acute effects of acrivastine (BW825C), a new antihistamine, compared with triprolidine on measures of central nervous system performance and subjective effects. Clin Pharmacol Ther. 1985 Oct;38(4):381–386. doi: 10.1038/clpt.1985.191. [DOI] [PubMed] [Google Scholar]
  5. Dollery C. T., Davies D. S., Draffan G. H., Dargie H. J., Dean C. R., Reid J. L., Clare R. A., Murray S. Clinical pharmacology and pharmacokinetics of clonidine. Clin Pharmacol Ther. 1976 Jan;19(1):11–17. doi: 10.1002/cpt197619111. [DOI] [PubMed] [Google Scholar]
  6. Hedges A., Turner P., Harry T. V. Preliminary studies on the central effects of lorazepam, a new benzodiazepine. J Clin Pharmacol New Drugs. 1971 Nov-Dec;11(6):423–427. [PubMed] [Google Scholar]
  7. Hindmarch I., Parrott A. C. A repeated dose comparison of the side effects of five antihistamines on objective assessments of psychomotor performance, central nervous system arousal and subjective appraisals of sleep and early morning behaviour. Arzneimittelforschung. 1978;28(3):483–486. [PubMed] [Google Scholar]
  8. Hindmarch I. Psychomotor function and psychoactive drugs. Br J Clin Pharmacol. 1980 Sep;10(3):189–209. doi: 10.1111/j.1365-2125.1980.tb01745.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Levander S., Hägermark O., Ståhle M. Peripheral antihistamine and central sedative effects of three H1-receptor antagonists. Eur J Clin Pharmacol. 1985;28(5):523–529. doi: 10.1007/BF00544062. [DOI] [PubMed] [Google Scholar]
  10. Mann A. H. The clinical relevance of psychometric testing. Eur J Clin Pharmacol. 1985;28 (Suppl):31–34. doi: 10.1007/BF00543707. [DOI] [PubMed] [Google Scholar]
  11. Nicholson A. N., Stone B. M. Antihistamines: impaired performance and the tendency to sleep. Eur J Clin Pharmacol. 1986;30(1):27–32. doi: 10.1007/BF00614191. [DOI] [PubMed] [Google Scholar]
  12. Nicholson A. N., Stone B. M. Performance studies with the H1-histamine receptor antagonists, astemizole and terfenadine. Br J Clin Pharmacol. 1982 Feb;13(2):199–202. doi: 10.1111/j.1365-2125.1982.tb01356.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Paton D. M., Webster D. R. Clinical pharmacokinetics of H1-receptor antagonists (the antihistamines). Clin Pharmacokinet. 1985 Nov-Dec;10(6):477–497. doi: 10.2165/00003088-198510060-00002. [DOI] [PubMed] [Google Scholar]
  14. Peck A. W., Fowle A. S., Bye C. A comparison of triprolidine and clemastine on histamine antagonism and performance tests in man: implications for the mechanism of drug induced drowsiness. Eur J Clin Pharmacol. 1975 Aug 14;8(6):455–463. doi: 10.1007/BF00562321. [DOI] [PubMed] [Google Scholar]
  15. Richards D. M., Brogden R. N., Heel R. C., Speight T. M., Avery G. S. Astemizole. A review of its pharmacodynamic properties and therapeutic efficacy. Drugs. 1984 Jul;28(1):38–61. doi: 10.2165/00003495-198428010-00003. [DOI] [PubMed] [Google Scholar]
  16. Smith J. M., Misiak H. Critical flicker frequency (CFF) and psychotropic drugs in normal human subjects-a review. Psychopharmacologia. 1976 May 28;47(2):175–182. doi: 10.1007/BF00735818. [DOI] [PubMed] [Google Scholar]
  17. Subhan Z., Hindmarch I. Psychopharmacological effects of vinpocetine in normal healthy volunteers. Eur J Clin Pharmacol. 1985;28(5):567–571. doi: 10.1007/BF00544068. [DOI] [PubMed] [Google Scholar]
  18. Turner P. Critical flicker frequency and centrally-acting drugs. Br J Ophthalmol. 1968 Mar;52(3):245–250. doi: 10.1136/bjo.52.3.245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Vincent J., Liminana R., Meredith P. A., Reid J. L. The pharmacokinetics, antihistamine and concentration-effect relationship of ebastine in healthy subjects. Br J Clin Pharmacol. 1988 Nov;26(5):497–502. doi: 10.1111/j.1365-2125.1988.tb05288.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Weiner M. Sedation and antihistaminics. Arzneimittelforschung. 1982;32(9A):1193–1195. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES